Source: Health Products Regulatory Authority (IE) Revision Year: 2021 Publisher: Actavis Group PTC ehf, Reykjavikurvegi 76-78, 220 Hafnarfjรถrdur, Iceland
Cetriz 10mg Film-coated Tablets.
| Pharmaceutical Form |
|---|
|
Film coated tablet. Film-coated, white or almost white convex, oval shaped, tablets. Scored on one side. The tablet can be divided into 2 equal doses. |
Each film-coated tablet contains cetirizine dihydrochloride 10 mg.
Excipients with known effect: contains lactose monohydrate 117.00 mg.
For the full list of excipients, see 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Cetirizine |
Cetirizine, a human metabolite of hydroxyzine, is a potent and selective antagonist of peripheral H1-receptors. In vitro receptor binding studies have shown no measurable affinity for other than ฮ1-receptors. |
| List of Excipients |
|---|
|
Tablet core: Cellulose, microcrystalline Film coating: Hypromellose |
Aluminium/Aluminium blisters.
Pack size: 7,10,14, 28 or 30 Tablets.
Not all pack sizes may be marketed.
Actavis Group PTC ehf, Reykjavikurvegi 76-78, 220 Hafnarfjรถrdur, Iceland
PA1380/054/001
Date of first authorisation: 07 July 2006
Date of last renewal: 07 July 2011
| Drug | Countries | |
|---|---|---|
| CETRIZ | Hong Kong, Ireland |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
